The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
Open accessAbstract
Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type 2 diabetes. Despite evidence for substantial genetic influence on LDL concentrations, pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy or toxicity, and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment. This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two independent studies showed that genotypes associated with statin-induced down-regulation of expression of the gene encoding GATM were associated with protection from statin-induced myopathy.116”
From Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ide, T., Brown‐Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El‐Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 96
RetractedThe Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationA Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citationBiological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationChromHMM: automating chromatin-state discovery and characterization
Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,482
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Cited by
Sorted by citations
Items 101–200 of 225
Interpreting Coronary Artery Disease Risk Through Gene–Environment Interactions in Gene Regulation
Findley, A. S., Richards, A. L., Petrini, C., Alazizi, A., Doman, E. R., Shanku, A. G., Davis, G. O., Hauff, N., Sorokin, Y., Wen, X., et al. (2019) · Genetics · doi:10.1534/genetics.119.302419 · Cited by 24
Pharmacogenomics of Hypertension and Heart Disease
Arwood, M. J., Cavallari, L. H., & Duarte, J. D. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0586-5 · Cited by 22
Shim, H., & Stephens, M. (2015) · The Annals of Applied Statistics · doi:10.1214/14-aoas776 · Cited by 20
Self-citationImpact of New Genomic Technologies on Understanding Adverse Drug Reactions
Maggo, S. D. S., Savage, R. L., & Kennedy, M. A. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0324-9 · Cited by 23
Lea, A. J., Peng, J., & Ayroles, J. F. (2022) · Genome Research · doi:10.1101/gr.276430.121 · Cited by 25
Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group
Stock, J. K. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.049 · Cited by 21
Cui, H., Wang, J., Zhang, Q., Dang, M.-M., Liu, H., Dong, Y. J., Zhang, L., Yang, F., Wu, J., & Tong, X. (2016) · Molecules · doi:10.3390/molecules21040464 · Cited by 21
Cardiovascular precision medicine – A pharmacogenomic perspective
Padmanabhan, S., du Toit, C., & Dominiczak, A. F. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.17 · Cited by 19
Bruckert, É., & Ferrières, J. (2014) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2014.01.011 · Cited by 19
Using systems approaches to address challenges for clinical implementation of pharmacogenomics
Karnes, J. H., Driest, S. L. V., Bowton, E., Weeke, P., Mosley, J. D., Peterson, J. F., Denny, J. C., & Roden, D. M. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1255 · Cited by 18
Resztak, J., Wei, J., Zilioli, S., Sendler, E. D., Alazizi, A., Mair-Meijers, H. E., Wu, P., Wen, X., Slatcher, R. B., Zhou, X., et al. (2023) · Genome Research · doi:10.1101/gr.276765.122 · Cited by 19
Statin use and self-reported swimming performance in US masters swimmers
Terpak, K., Guthrie, S. K., & Erickson, S. R. (2014) · Journal of Sports Sciences · doi:10.1080/02640414.2014.942688 · Cited by 17
Khan, A., Tian, L., Zhang, C., Yuan, K., & Xu, S. (2016) · Scientific Reports · doi:10.1038/srep18755 · Cited by 17
Qu, W., Gurdziel, K., Piqué-Regi, R., & Ruden, D. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00395 · Cited by 20
Statin-induced changes in gene expression in EBV-transformed and native B-cells
Bolotin, E., Armendariz, A. D., Kim, K., Heo, S., Boffelli, D., Tantisira, K. G., Rotter, J. I., Krauss, R. M., & Medina, M. W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt512 · Cited by 17
Self-citationPharmacogenomics of statin therapy
Hopewell, J. C., Reith, C. A., & Armitage, J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000125 · Cited by 17
Self-citationCardiovascular pharmacogenomics; state of current knowledge and implementation in practice
Shahabi, P., & Dubé, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.025 · Cited by 18
Liu, M., Fan, F., Zhang, Y., & Li, J. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03019-3 · Cited by 16
Theusch, E., Kim, K., Stevens, K., Smith, J. D., Chen, Y. I., Rotter, J. I., Nickerson, D. A., & Medina, M. W. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.12 · Cited by 16
Self-citationInteractions between genetic variation and cellular environment in skeletal muscle gene expression
Taylor, D. L., Knowles, D. A., Scott, L. J., Ramirez, A. H., Casale, F. P., Wolford, B. N., Guan, L., Varshney, A., Albanus, R. D., Parker, S. C. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195788 · Cited by 15
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43938-5 · Cited by 14
A signature of Neanderthal introgression on molecular mechanisms of environmental responses
Findley, A. S., Zhang, X., Boye, C., Lin, Y. L., Kalita, C. A., Barreiro, L., Lohmueller, K. E., Pique-Regi, R., & Luca, F. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009493 · Cited by 14
Peric, D., Barragán, I., Giraud-Triboult, K., Egesipe, A.-L., Meyniel‐Schicklin, L., Cousin, C., Lotteau, V., Petit, V., Touhami, J., Battini, J., et al. (2015) · Stem Cells · doi:10.1002/stem.2107 · Cited by 14
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial
Murphy, W. A., Lin, N., Damask, A., Schwartz, G. G., Steg, P. G., Szarek, M. J., Banerjee, P., Fazio, S., Manvelian, G. Z., Pordy, R. C., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003503 · Cited by 16
Does Reduced Creatine Synthesis Protect against Statin Myopathy?
Ballard, K. D., & Thompson, P. D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.012 · Cited by 14
Creatine as a Candidate to Prevent Statin Myopathy
Balestrino, M., & Adriano, E. (2019) · Biomolecules · doi:10.3390/biom9090496 · Cited by 13
Walker, L. E., Yip, V. L. M., & Pirmohamed, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386882-4.00020-7 · Cited by 14
Dietary modulators of statin efficacy in cardiovascular disease and cognition
Wang, H., Blumberg, J. B., Chen, C. ‐. O., Choi, S., Corcoran, M. P., Harris, S. S., Jacques, P. F., Kristo, A. S., Lai, C., Lamon‐Fava, S., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.04.001 · Cited by 14
Stem Cell Models for Context-Specific Modeling in Psychiatric Disorders
Seah, C., Huckins, L. M., & Brennand, K. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.033 · Cited by 12
Distant regulatory effects of genetic variation in multiple human tissuesPreprint
Jo, B., He, Y. M., Strober, B. J., Parsana, P., Aguet, F., Brown, A. A., Castel, S. E., Gamazon, E. R., Gewirtz, A. D., Gliner, G., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/074419 · Cited by 14
Self-citationHandelman, S. K., Seweryn, M. T., Smith, R. M., Hartmann, K., Wang, D., Pietrzak, M., Johnson, A. D., Kloczkowski, A., & Sadée, W. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s8-s8 · Cited by 12
Muscle phenotype of AGAT- and GAMT-deficient mice after simvastatin exposure
Sasani, A., Hornig, S., Grzybowski, R., Cordts, K., Hanff, E., Tsikas, D., Böger, R. H., Gerloff, C. P., Isbrandt, D., Neu, A. D., et al. (2019) · Amino Acids · doi:10.1007/s00726-019-02812-4 · Cited by 12
ZNF542P is a pseudogene associated with LDL response to simvastatin treatment
Kim, K., Theusch, E., Kuang, Y., Dosé, A. C., Mitchel, K., Cubitt, C. C., Chen, Y. I., Krauss, R. M., & Medina, M. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-30859-y · Cited by 12
Self-citationMany long intergenic non-coding RNAs distally regulate mRNA gene expression levelsPreprint
McDowell, I. C., Pai, A. A., Guo, C., Vockley, C. M., Brown, C. D., Reddy, T. E., & Engelhardt, B. E. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/044719 · Cited by 12
Self-citationGenetic Variation in Statin Intolerance and a Possible Protective Role for UGT1A1
Willrich, M. A. V., Kaleta, E. J., Bryant, S. C., Spears, G. M., Train, L. J., Peterson, S. E., Lennon, V. A., Kopecky, S. L., & Baudhuin, L. M. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0146 · Cited by 11
Taylor, B. A., Panza, G. A., Ballard, K. D., White, C. M., & Thompson, P. D. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.05.018 · Cited by 11
Statin-induced liver and muscle toxicities
Lee, W. S., & Kim, J. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-019-0002-3 · Cited by 10
Xiang, Q., Zhang, X., Mu, G., Wang, Z., Liu, Z., Xie, Q., Hu, K., Zhang, Z., Ma, L., Jiang, J., et al. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03029-1 · Cited by 11
Lang, L.-J., Wang, M., Lei, C., Shen, Y., Zhu, Q.-J., Diao, H.-M., Chen, H., Shen, L., Dong, X., Jiang, B., et al. (2021) · Planta Medica · doi:10.1055/a-1716-0958 · Cited by 11
Glucocorticoids unmask silent non-coding genetic risk variants for common diseases
Nguyen, T. T. L., Gao, H., Liu, D., Philips, T. J., Ye, Z., Lee, J., Shi, G., Copenhaver, K. M., Zhang, L., Wei, L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1045 · Cited by 10
Bayesian Structured Sparsity from Gaussian FieldsPreprint
Engelhardt, B. E., & Adams, R. P. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1407.2235 · Cited by 18
Self-citationMärz, W., & Laufs, U. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx586 · Cited by 11
Functional relevance for multiple sclerosis-associated genetic variants
Lin, X., Deng, F., Mo, X., Wu, L., & Lei, S. (2014) · Immunogenetics · doi:10.1007/s00251-014-0803-4 · Cited by 10
Maranville, J., & Rienzo, A. D. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.129 · Cited by 10
Zhong, Y., De, T., Mishra, M., Avitia, J., Alarcón, C., & Perera, M. A. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.12.005 · Cited by 8
Lost in Translation ( LiT ): IUPHAR Review 6
Dollery, C. T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12580 · Cited by 9
The adjuvant value of Herba Cistanches when used in combination with statin in murine models
Wat, E., Ng, C., Koon, C. M., Zhang, C., Gao, S., Tomlinson, B., & Lau, C. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-10008-7 · Cited by 9
Effect of statin on semen quality characteristics
Banihani, S. A. (2020) · Andrologia · doi:10.1111/and.13592 · Cited by 9
Gupta, M., Smokovski, I., Chatzis, D., Spring, K. J., Mehndiratta, M. M., Beran, R. G., & Bhaskar, S. M. M. (2025) · CNS Drugs · doi:10.1007/s40263-025-01222-3 · Cited by 9
Messas, N., Dubé, M., & Tardif, J. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0679-5 · Cited by 8
Ooi, B. N. S., Raechell, R., Ying, A. F., Koh, Y. Z., Jin, Y., Yee, S. W. L., Lee, J. H. S., Chong, S. S., Tan, J. W. C., Liu, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.605764 · Cited by 8
Can we further optimize statin therapy to increase tolerability?
Ruscica, M., Reiner, Ž., & Sirtori, C. R. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1615436 · Cited by 8
Resztak, J., Wei, J., Zilioli, S., Sendler, E. D., Alazizi, A., Mair-Meijers, H. E., Wu, P., Wen, X., Slatcher, R. B., Zhou, X., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.30.462672 · Cited by 7
Sun, M., Wang, Q., Wu, L. J., Zhang, Y., Ren, J., & Qu, X. (2025) · ACS Nano · doi:10.1021/acsnano.5c14098 · Cited by 7
Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population
Olloquequi, J., Castro, P. G., & Díaz‐Peña, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911758 · Cited by 7
Lea, A. J., Peng, J., & Ayroles, J. F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.04.467311 · Cited by 6
Gene expression changes in lymphoblastoid cell lines and primary B cells by dexamethasone
Park, H., Dahlin, A., Qiu, W., & Tantisira, K. G. (2018) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000365 · Cited by 6
Balestrino, M., & Adriano, E. (2020) · Amino Acids · doi:10.1007/s00726-020-02838-z · Cited by 6
A Bayesian test to identify variance effectsPreprint
Dumitrascu, B., Darnell, G., Ayroles, J. F., & Engelhardt, B. E. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1512.01616 · Cited by 6
Self-citationEffect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins
Bertolami, A., Botelho, P. B., Macedo, L. F. L., Abdalla, D. S. P., Faludi, A. Á., Galasso, M., & de Castro, I. A. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.05.018 · Cited by 5
Streja, E., Streja, D. A., Soohoo, M., Kleine, C., Hsiung, J., Park, C., & Moradi, H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.05.007 · Cited by 5
Genetic Determinants of Statin-induced Myopathy: A Network Meta-analysis of Observational Studies
Sridharan, K., & Sivaramakrishnan, G. (2025) · Current Clinical Pharmacology · doi:10.2174/0127724328356429250315163111 · Cited by 5
Liu, D., Guo, K., Liu, Y., Yu, X., Guan, X., & Guan, X. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1597445 · Cited by 4
Eadon, M. T., Hause, R. J., Stark, A. L., Cheng, Y., Wheeler, H. E., Burgess, K., Benson, E. A., Cunningham, P. N., Bacallao, R. L., Dagher, P. C., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030661 · Cited by 4
Bhoj, E. J. K., Rajabi, F., Baker, S. W., Santani, A., & Tan, W. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.103903 · Cited by 5
Mangravite, L. M., Engelhardt, B. E., Stephens, M., & Krauss, R. M. (2014) · Nature · doi:10.1038/nature13630 · Cited by 4
Self-citationBayesian group latent factor analysis with structured sparsityPreprint
Zhao, S., Gao, C., Mukherjee, S., & Engelhardt, B. E. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1411.2698 · Cited by 5
Self-citationA Divide and Conquer Strategy for High Dimensional Bayesian Factor ModelsPreprint
Sabnis, G. S., Pati, D., Engelhardt, B. E., & Pillai, N. S. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1612.02875 · Cited by 4
Self-citationCharacterization of caffeine response regulatory variants in vascular endothelial cells
Boye, C., Kalita, C. A., Findley, A. S., Alazizi, A., Wei, J., Wen, X., Piqué-Regi, R., & Luca, F. (2024) · eLife · doi:10.7554/elife.85235 · Cited by 2
Pharmacogenetics of Cardiovascular Disease: Genetic Variation and Statin Intolerance
Petřková, J., Táborský, M., & Petřek, M. (2018) · InTech eBooks · doi:10.5772/intechopen.79518 · Cited by 3
Yan, K. K., Zhao, H., Wu, J. T. K., & Pang, H. (2020) · Genetic Epidemiology · doi:10.1002/gepi.22341 · Cited by 3
Identifying Genetic Modulators of Statin Response Using Subject-Derived Lymphoblastoid Cell Lines
Kuang, Y., Theusch, E., Krauss, R. M., & Medina, M. W. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0197 · Cited by 3
Self-citationKhan, A. R., Shah, S. H., Ajaz, S., Firasat, S., Abid, A., & Raza, A. (2022) · Evolutionary Bioinformatics · doi:10.1177/11769343221095834 · Cited by 3
Theusch, E., Ting, F., Qin, Y., Stevens, K., Naidoo, D., King, S. M., Yang, N. V., Orr, J., Han, Y., Cyster, J. G., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01366-9 · Cited by 2
Self-citationDaneshi, N., Holliday, E. G., Hancock, S. J., Schneider, J., Scott, R. J., Attia, J., & Milward, E. A. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s123719 · Cited by 3
Statin intolerance: diagnosis, treatment and alternative therapies
Naderi, S., & Cho, L. (2014) · Clinical Lipidology · doi:10.2217/clp.14.23 · Cited by 3
Detecting signals in pharmacogenomic genome-wide association studies
Wakefield, J., Skrivankova, V. W., Hsu, F.-C., Sale, M. M., & Heagerty, P. J. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.44 · Cited by 3
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review
González‐Iglesias, E., Novalbos, J., & Abad‐Santos, F. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2547565 · Cited by 2
Sychev, D. A., Оstroumova, Т. М., Ostroumova, O. D., Кочетков, А. И., Владимировна, Б. С., & Mironova, E. V. (2023) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2023-11-3-252-270 · Cited by 2
Investigation of the Association of GATM Gene Polymorphisms with Statin-Induced Myopathy
Hussain, A., Zakria, M., Tariq, S. A., Rauf, M. A., Ahmad, J., Rasool, M. F., & Ali, I. (2023) · Precision Medicine Communications · doi:10.55627/pmc.003.02.0430 · Cited by 2
Gao, H., Wei, L., Indulkar, S., Nguyen, T. T. L., Liu, D., Ho, M., Zhang, C., Li, H., Weinshilboum, R. M., Ingle, J. N., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01861-2 · Cited by 2
Yang, R., Hu, N., Chen, H., 李文强, & Zheng, T. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06224-y · Cited by 1
Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
Pirmohamed, M. (2014) · Cited by 1
Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes
Zubkowski, A., Sferruzzi-Perri, A. N., & Wishart, D. S. (2025) · Acta Physiologica · doi:10.1111/apha.14273 · Cited by 1
Li, X., Sun, S., Xu, X., Zhao, Z., & Li, W. (2018) · Drug Research · doi:10.1055/a-0677-2944 · Cited by 1
Kalita, C. A., & Gusev, A. (2022) · Genome biology · doi:10.1186/s13059-022-02708-9 · Cited by 2
Bayesian group latent factor analysis with structured sparse priorsPreprint
Zhao, S., Gao, C., Mukherjee, S., & Engelhardt, B. E. (2014) · arXiv (Cornell University) · Cited by 1
Self-citationFuture Directions in Pharmacogenomics Discovery in Cardiovascular Disease
Friede, K. A., & Voora, D. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0002 · Cited by 1
A novel method to identify cell-type specific regulatory variants and their role in cancer riskPreprint
Kalita, C. A., & Gusev, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.11.468278 · Cited by 1
Nirmalan, S., Arif, S. J., Wei, J., Priya, S., Blekhman, R., Piqué-Regi, R., & Luca, F. (2026) · medRxiv · doi:10.64898/2026.01.30.26344673 · Cited by 1
Distrofias musculares, miopatías metabólicas y tóxicas
Cabrera‐Serrano, M. (2015) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2015.03.004
Endothelial Dysfunction and Cardiovascular Disease: Critical Target for Cell-Based Therapies
Varudkar, N. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/7329
Expression Quantitative Trait Locus Analysis Identifies Novel Genes for Statin Myopathy
Voora, D. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000611
Genetic association study of plasma creatine kinase levels in the Montreal Heart
Zetler, R. Z. (2014)
Homoarginine and l-Arginine/Glycine Amidinotransferase in Stroke
Choe, C., Schwedhelm, E., & Atzler, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_17
Divide-and-conquer for covariance matrix estimationPreprint
Sabnis, G. S., Pati, D., Engelhardt, B. E., & Pillai, N. S. (2016) · arXiv (Cornell University)
Self-citationPharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery
Turner, R. M., & Pirmohamed, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_5
Effect of EBV-Transformation on Oxidative Phosphorylation Physiology in Human Cell linesPreprint
Weinstein, R. N., & Crawford, D. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.16.878025
Genetic Risk Factors for Statin-Associated Muscle Symptoms (SAMS)
Rosario-Berrios, A. N., Duconge-Soler, J., & Ruaño, G. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_11
Metadata
- Authors
- Mangravite, L. M., Engelhardt, B. E., Medina, M. W., Smith, J. D., Brown, C. D., Chasman, D. I., Mecham, B. H., Howie, B., Shim, H., Naidoo, D., Feng, Q., Rieder, M. J., Chen, Y.-D. I., Rotter, J. I., Ridker, P. M., Hopewell, J. C., Parish, S., Armitage, J., Collins, R., Wilke, R. A., Nickerson, D. A., Stephens, M., & Krauss, R. M.
- Affiliations
- Sage Bionetworks (US)
- Duke University (US)
- University of Washington (US)
- University of Pennsylvania (US)
- Brigham and Women's Hospital (US)
- University of Chicago (US)
- Vanderbilt University Medical Center (US)
- The Lundquist Institute (US)
- University of Oxford (GB)
- Corresponding author
- Mangravite, Lara M.
- Stephens, Matthew
- Krauss, Ronald M.
- ORCID
- Mangravite, Lara M.
- Engelhardt, Barbara E.
- Medina, Marisa W.
- Smith, Joshua D.
- Chasman, Daniel I.
- Shim, Heejung
- Feng, QiPing
- Rieder, Mark J.
- Chen, Yii.-Der I.
- Rotter, Jerome I.
- Ridker, Paul M.
- Hopewell, Jemma C.
- Parish, Sarah
- Armitage, Jane
- Collins, Rory
- Wilke, Russell A.
- Nickerson, Deborah A.
- Stephens, Matthew
- Krauss, Ronald M.
- Venue
- Nature
- Published
- 2013-08-28
- Volume
- 502
- Issue
- 7471
- Pages
- 377-380
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3933266
- OpenAlex
- W1985629708
- Cited by
- 224
- References
- 41
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 14 · 2022: 12 · 2021: 13 · 2020: 12 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 22 · 2015: 25 · 2014: 42 · 2013: 8
- FWCI
- 31.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- British Heart Foundation
- National Institutes of Health (UL1TR000124)
- National Heart, Lung, and Blood Institute (R01HL104133, U01HL069757, U01-HL69757)
- National Human Genome Research Institute (R00HG006265, K99/R00HG006265, R56HG002585, HG002585, K99HG006265, R01HG002585)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK063491)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- statin-induced myopathy, GATM, creatine synthesis, expression quantitative trait loci, simvastatin, gene expression regulation, statin toxicity, hepatocyte gene expression, drug-gene interactions, lymphoblastoid cell lines
- MeSH terms
- Amidinotransferases, Cell Line, Cholesterol, Gene Expression Regulation, Humans, Lymphocytes, Muscular Diseases, Transcription, Genetic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Sterol Regulatory Element Binding Proteins, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
